David R. Drover
Department of Anesthesia
Stanford University School of Medicine
California
USA
Name/email consistency: high
- Determination of the pharmacodynamic interaction of propofol and remifentanil during esophagogastroduodenoscopy in children. Drover, D.R., Litalien, C., Wellis, V., Shafer, S.L., Hammer, G.B. Anesthesiology (2004)
- Patient State Index: titration of delivery and recovery from propofol, alfentanil, and nitrous oxide anesthesia. Drover, D.R., Lemmens, H.J., Pierce, E.T., Plourde, G., Loyd, G., Ornstein, E., Prichep, L.S., Chabot, R.J., Gugino, L. Anesthesiology (2002)
- Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Drover, D.R., Angst, M.S., Valle, M., Ramaswamy, B., Naidu, S., Stanski, D.R., Verotta, D. Anesthesiology (2002)
- Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Drover, D., Lemmens, H., Naidu, S., Cevallos, W., Darwish, M., Stanski, D. Clin. Ther (2000)
- Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Drover, D.R., Lemmens, H.J. Anesthesiology (1998)
